Cholesteryl ester transfer protein: the physiological and molecular characteristics in the pathogenesis of atherosclerosis and Alzheimer’s disease

Cholesteryl ester transfer protein: the physiological and molecular characteristics in the pathogenesis of atherosclerosis and Alzheimer’s disease

Cholesteryl ester transfer protein (CETP) is involved in reverse cholesterol transport, mediates the exchange of cholesteryl esters for triglycerides between high-density lipoproteinsand low-density lipoproteins/very low-density lipoproteins. Lipid transfer mechanism by CETP is unknown. Two main mod...

Full description

Bibliographic Details
Main Authors:	Justyna Pawlik, Dorota Wrześniok
Format:	Article
Language:	English
Published:	Index Copernicus International S.A. 2019-08-01
Series:	Postępy Higieny i Medycyny Doświadczalnej
Subjects:	cholesterol coronary artery disease high-density lipoprotein torcetrapib
Online Access:	http://phmd.pl/gicid/01.3001.0013.3673

Similar Items

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism
by: Margaret E. Brousseau, et al.
Published: (2009-07-01)

Biochemical characterization of cholesteryl ester transfer protein inhibitors
by: Mollie Ranalletta, et al.
Published: (2010-09-01)

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport[S]
by: Eric J. Niesor, et al.
Published: (2010-12-01)

Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans
by: Charles C. Schwartz, et al.
Published: (2004-09-01)

Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
by: Bela F. Asztalos, et al.
Published: (2004-03-01)

ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice
by: Richard G. Lee, et al.
Published: (2005-06-01)

Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr−/− mice[S]
by: Jinghua Bie, et al.
Published: (2014-04-01)

Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase
by: Miriam Lee-Rueckert, et al.
Published: (2008-02-01)

Recent progress in the management of atherosclerosis and hyperlipidemia
by: M. V. Ezhov
Published: (2017-12-01)

Fatty acids differentially regulate hepatic cholesteryl ester formation and incorporation into lipoproteins in the liver of the mouse
by: Chonglun Xie, et al.
Published: (2002-09-01)

Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse
by: David Masson, et al.
Published: (2004-03-01)

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
by: J.D. Curb, et al.
Published: (2004-05-01)

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia
by: Jamal Jafari, et al.
Published: (2019-10-01)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
by: Jing-Kang Shen, et al.
Published: (2012-05-01)

Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism
by: Margaret R. Diffenderfer, et al.
Published: (2012-06-01)

Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism
by: John S. Millar, et al.
Published: (2008-03-01)

Effect of crocin, a carotenoid from saffron, on plasma cholesteryl ester transfer protein and lipid profile in subjects with metabolic syndrome: A double blind randomized clinical trial
by: Ali Javandoost, et al.
Published: (2017-10-01)

Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits
by: Shirya Rashid, et al.
Published: (2001-02-01)

In vitro incorporation of cholesterol-14C in to very low density lipoprotein cholesteryl esters
by: Yasuo Akanuma, et al.
Published: (1968-09-01)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
by: Emily E. Morin, et al.
Published: (2020-12-01)

ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters
by: Richard E. Morton, et al.
Published: (2019-11-01)

Cellular cholesterol efflux mediated by HDL isolated from subjects with low HDL levels and coronary artery disease
by: Luciana Uint, et al.
Published: (2003-07-01)

Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis
by: Tuli Kou, et al.
Published: (2021-03-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion
by: Ying Shen, et al.
Published: (2019-06-01)

LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis
by: John T. Melchior, et al.
Published: (2013-09-01)

C323 of SR-BI is required for SR-BI-mediated HDL binding and cholesteryl ester uptake[S]
by: Ling Guo, et al.
Published: (2011-12-01)

Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection[S]
by: Ronald W. Clark, et al.
Published: (2010-05-01)

Role of polymorphisms of the cholesteryl ester transfer protein gene in atherogenesis
by: Kakko, S. (Sakari)
Published: (2000)

Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
by: Guoqing Cao, et al.
Published: (2011-12-01)

Cholesteryl ester transfer proteins from different species do not have equivalent activities[S]
by: Richard E. Morton, et al.
Published: (2014-02-01)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
by: Xu W, et al.
Published: (2020-11-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
by: Sandra Kunnen, et al.
Published: (2012-09-01)

Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI
by: May Brundert, et al.
Published: (2006-11-01)

Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines
by: Libo Wang, et al.
Published: (2003-04-01)

Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease
by: Jun Gu, et al.
Published: (2019-08-01)

Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease
by: Ya-Ching Huang, et al.
Published: (2014-12-01)

Cholesteryl ester transfer protein and its inhibitors
by: Sudichhya Shrestha, et al.
Published: (2018-01-01)

Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia
by: Jean-Charles Hogue, et al.
Published: (2004-06-01)